[go: up one dir, main page]

AR030834A1 - Uso de una formulacion en la fabricacion de un producto nutritivo, util para incrementar la mineralizacion osea en un ser humano - Google Patents

Uso de una formulacion en la fabricacion de un producto nutritivo, util para incrementar la mineralizacion osea en un ser humano

Info

Publication number
AR030834A1
AR030834A1 ARP010104641A ARP010104641A AR030834A1 AR 030834 A1 AR030834 A1 AR 030834A1 AR P010104641 A ARP010104641 A AR P010104641A AR P010104641 A ARP010104641 A AR P010104641A AR 030834 A1 AR030834 A1 AR 030834A1
Authority
AR
Argentina
Prior art keywords
mineralization
formulation
human
manufacture
useful
Prior art date
Application number
ARP010104641A
Other languages
English (en)
Inventor
John Lasekan
Michael Montalto
John D Benson
Marc Masor
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23097261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR030834(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR030834A1 publication Critical patent/AR030834A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere el uso de una formulacion en la fabricacion de un producto nutritivo, util para incrementar la mineralizacion osea de un ser humano y, más preferentemente, un lactante o un nino menor de 2 anos. La formulacion comprende una fuente de calcio y una mezcla de grasas pobre en ácido palmítico. La mayor mineralizacion da como resultado la produccion de un pico más alto de masa osea y disminuye de forma correspondiente la incidencia de osteoporosis.
ARP010104641A 2001-04-24 2001-10-02 Uso de una formulacion en la fabricacion de un producto nutritivo, util para incrementar la mineralizacion osea en un ser humano AR030834A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28614001P 2001-04-24 2001-04-24

Publications (1)

Publication Number Publication Date
AR030834A1 true AR030834A1 (es) 2003-09-03

Family

ID=23097261

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104641A AR030834A1 (es) 2001-04-24 2001-10-02 Uso de una formulacion en la fabricacion de un producto nutritivo, util para incrementar la mineralizacion osea en un ser humano

Country Status (14)

Country Link
US (2) US6620427B2 (es)
EP (1) EP1252824B1 (es)
JP (1) JP2002315503A (es)
AR (1) AR030834A1 (es)
AT (1) ATE327680T1 (es)
BR (1) BR0201023A (es)
CA (1) CA2357459C (es)
CY (1) CY1106141T1 (es)
DE (1) DE60120114T2 (es)
DK (1) DK1252824T3 (es)
ES (1) ES2265386T3 (es)
MX (1) MXPA01011436A (es)
PT (1) PT1252824E (es)
SA (1) SA02220671B1 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013787A1 (en) * 2002-06-28 2004-01-22 Theuer Richard C. Fat compositions for infant formula and methods therefor
US8815279B2 (en) * 2003-02-10 2014-08-26 University College London Baby feeding formula and system
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
US7323200B2 (en) * 2003-08-18 2008-01-29 Abbott Laboratories Calcium fortified, soy based, infant nutritional formulas
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
US20050129825A1 (en) * 2003-12-16 2005-06-16 Gray Kimberley H. Stabilization of milk-based products
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
JP4759289B2 (ja) * 2005-03-02 2011-08-31 国立大学法人北海道大学 カルシウム吸収促進組成物およびその利用
BRPI0620083A2 (pt) 2005-12-19 2011-11-01 Abbott Lab usos de b-hidróxi-b-metilbutirato
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
US20080200425A1 (en) * 2007-02-16 2008-08-21 Kurtz Seymour J Methods and compositions for regulating bone mineral density
JP5384333B2 (ja) * 2007-04-27 2014-01-08 株式会社明治 ホエイタンパク質を高濃度で含む液状栄養組成物およびその製造方法
WO2008132713A1 (en) * 2007-04-29 2008-11-06 Shemen Industries Ltd. Nourishing oil composition for infants and young children
DE102007022694A1 (de) * 2007-05-11 2008-11-13 Humana Milchunion Eg Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme
CN104212844A (zh) * 2007-06-01 2014-12-17 索拉兹米公司 在微生物中生产油
IL184982A0 (en) 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
JP6066463B2 (ja) 2008-04-09 2017-01-25 テラヴィア ホールディングス， インコーポレイテッド 微生物バイオマス及び微生物油の直接的化学修飾
EP2462818A1 (en) * 2008-06-16 2012-06-13 N.V. Nutricia Infant formula composition with fat gradient
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
SI2554056T1 (sl) 2008-09-02 2020-02-28 N.V. Nutricia Prehranski sestavki z lipidnimi globulami velikega premera z oblogo, ki obsega fosfolipide
US20100303989A1 (en) 2008-10-14 2010-12-02 Solazyme, Inc. Microalgal Flour
US20100297296A1 (en) * 2008-10-14 2010-11-25 Solazyme, Inc. Healthier Baked Goods Containing Microalgae
CN107034142A (zh) * 2008-11-28 2017-08-11 泰拉瑞亚控股公司 在异养型微生物中制备特制油
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
PH12012501511A1 (en) 2010-01-29 2016-05-25 Abbott Lab Nutritional emulsions comprising calcium mhb
US8916217B2 (en) 2010-01-29 2014-12-23 Abbott Laboratories Aseptically packaged nutritional liquids comprising HMB
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
CN103124499B (zh) * 2010-05-28 2016-09-28 泰拉瑞亚控股公司 包含特制油的食品组合物
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
ES2746074T3 (es) 2010-11-03 2020-03-04 Corbion Biotech Inc Aceites microbianos con puntos de fluidez reducidos, fluidos dieléctricos producidos a partir de estos y métodos relacionados
CN110066836A (zh) 2011-02-02 2019-07-30 柯碧恩生物技术公司 产自重组产油微生物的定制油
EP2705138B1 (en) 2011-05-06 2017-03-22 TerraVia Holdings, Inc. Genetically engineered microorganisms that metabolize xylose
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
BR112014025719A8 (pt) 2012-04-18 2017-10-03 Solazyme Inc Óleos customizados
US9719114B2 (en) 2012-04-18 2017-08-01 Terravia Holdings, Inc. Tailored oils
US10098371B2 (en) 2013-01-28 2018-10-16 Solazyme Roquette Nutritionals, LLC Microalgal flour
EP2983643A4 (en) 2013-04-12 2016-12-28 Univ Columbia PROCESS FOR HOST CELL HOMING AND TOOTH MARK GENERATION
EP2993993A2 (en) 2013-04-26 2016-03-16 Solazyme, Inc. Low polyunsaturated fatty acid oils and uses thereof
FR3009619B1 (fr) 2013-08-07 2017-12-29 Roquette Freres Compositions de biomasse de microalgues riches en proteines de qualite sensorielle optimisee
JP6517196B2 (ja) 2013-10-04 2019-05-22 テラヴィア ホールディングス， インコーポレイテッド 調整油
PL3091973T3 (pl) 2013-11-01 2019-01-31 N.V. Nutricia Kompozycja lipidowa do poprawy składu ciała podczas nadganiania wzrostu
WO2015085549A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. An age-tailored nutrition system for an infant
US9394550B2 (en) 2014-03-28 2016-07-19 Terravia Holdings, Inc. Lauric ester compositions
EP3620517A3 (en) 2014-07-10 2020-07-29 Corbion Biotech, Inc. Ketoacyl acp synthase genes and uses thereof
EP3212180A1 (en) * 2014-10-27 2017-09-06 Nestec S.A. Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
KR101559937B1 (ko) * 2015-02-25 2015-10-14 주식회사 진용 홍화씨 추출물, 보스웰리아 추출물 및 황금 추출물을 유효성분으로 함유하는 뼈 길이 성장 촉진용 및 골밀도 증가용 식품 조성물
ES2742522T3 (es) 2015-10-15 2020-02-14 Nutricia Nv Fórmulas para lactantes con arquitectura lipídica especial para promover el crecimiento saludable
CN109475166A (zh) * 2016-08-05 2019-03-15 雀巢产品技术援助有限公司 促进肠道舒适度以及最佳脂肪和钙吸收的用于婴儿和幼儿的脂质组合物
EP4464316A3 (en) 2016-12-09 2025-01-29 N.V. Nutricia Nutritional composition for improving cell membranes
WO2019131712A1 (ja) 2017-12-26 2019-07-04 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649295A (en) * 1970-06-01 1972-03-14 American Home Prod Humanized fat compositions and infant formulas thereof
GB8317248D0 (en) * 1983-06-24 1983-07-27 Wyeth John & Brother Ltd Fat compositions
JPS61209544A (ja) * 1985-03-14 1986-09-17 Ueda Seiyu Kk 人乳脂類似油脂
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
ES2188855T3 (es) * 1997-07-22 2003-07-01 Nestle Sa Composicion lipida para formula infantil y procedimiento de preparacion.
JP2000023639A (ja) * 1998-05-06 2000-01-25 Yoshio Inoue マヨネーズ、ドレッシング、カレールウ、フライ、てんぷら、コロッケ、アイスクリームなどの脂肪が腸管から吸収されるのを抑制する方法
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate

Also Published As

Publication number Publication date
US6620427B2 (en) 2003-09-16
ES2265386T3 (es) 2007-02-16
PT1252824E (pt) 2006-10-31
EP1252824B1 (en) 2006-05-31
CY1106141T1 (el) 2011-06-08
DK1252824T3 (da) 2006-10-02
BR0201023A (pt) 2003-01-14
EP1252824A3 (en) 2004-01-07
US20040062820A1 (en) 2004-04-01
DE60120114D1 (de) 2006-07-06
JP2002315503A (ja) 2002-10-29
SA02220671B1 (ar) 2006-12-19
EP1252824A2 (en) 2002-10-30
ATE327680T1 (de) 2006-06-15
US6849268B2 (en) 2005-02-01
DE60120114T2 (de) 2007-01-04
US20030026860A1 (en) 2003-02-06
CA2357459A1 (en) 2002-10-24
CA2357459C (en) 2010-02-02
MXPA01011436A (es) 2005-06-30

Similar Documents

Publication Publication Date Title
AR030834A1 (es) Uso de una formulacion en la fabricacion de un producto nutritivo, util para incrementar la mineralizacion osea en un ser humano
CO5210902A1 (es) Producto de confiteria mascable
BR0109603A (pt) Novas composições cosméticas, de higiene pessoal, agente de limpeza e de suplemento nutricional e métodos para fabricar e utilizar as mesmas
ES2625294T3 (es) Suplemento alimenticio biológicamente activo
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
BR0116376B1 (pt) composiÇço de perfume, produto de consumo, composiÇÕes para tratamento de tecido, de produto pessoal, para tratamento de superfÍcie dura e para tratamento de ar, e, mÉtodo nço terapÊutico para proporcionar benefÍcios de humor positivo, particularmente, benefÍcios de relaxamento, a um indivÍduo.
PL334348A1 (en) Method of treating prostate diseases using vitamin d formulations of retarded and/or prolonged release
NO962088D0 (no) Preparat for in vivo-produksjon av terapeutiske produkter
BG108443A (en) Substituted oxazoliidinones for combinational therapy
WO2004066918A3 (en) Long wear cosmetic composition
ATE469961T1 (de) Film mit reinigungsmittel
AR029191A1 (es) Procedimiento para preparar masa de papas laminable a partir de papa cruda
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
AR026695A1 (es) Producto de confiteria conteniendo hidrocoloides
BR0111176A (pt) Massa para preparar chips de tortilla com borbulhamento controlado da superfìcie
AU3259099A (en) Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method
ITMI20020990A0 (it) Formulazioni utili nel trattamento dell'impotenza maschile e femminile
IT1315252B1 (it) Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa
BG105275A (en) Tan-1057 derivatives
TW200510308A (en) Isophthalic acid derivatives
ES2035092T3 (es) Producto liquido para el tratamiento estetico de la piel y su procedimiento de fabricacion.
SE0001916D0 (sv) Novel formulation
ES2102652T3 (es) Preparacion para el tratamiento profilactico y terapeutico de la caries dental.
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
AR013824A1 (es) Producto alimenticio expandido para el consumo humano o animal y un procedimiento para su preparacion

Legal Events

Date Code Title Description
FA Abandonment or withdrawal